The Guidelines for Management of TB, DR-TB and Leprosy in Ethiopia is the national programme guideline for tuberculosis, drug-resistant tuberculosis and leprosy. The file hosted here is the Sixth Edition, November 2017, published by the Federal Ministry of Health in Addis Ababa. It runs to 217 pages.
Unlike a treatment guideline that only states regimens, this document is written as a programme manual. It carries the case definitions, the registration and recording rules, the treatment regimens and the monitoring framework in one place, because in a national TB programme those things have to agree with each other.
Practise it on a case. Soma, a free practice tool from Hepius, has a case of a 28-year-old woman with three months of cough and weight loss. You take the history, examine, order tests and decide, then get scored feedback.
What the guideline covers
- Key recommendations, gathered at the front so the changes from the previous edition can be found quickly
- Introduction to tuberculosis and the national strategy, including an overview of the disease and the programme’s direction
- Diagnosis of tuberculosis, including diagnosis in children, diagnosis in people living with HIV, and the diagnosis of drug-resistant TB in children
- Treatment of latent TB infection: national policy, identifying the eligible population, management of contacts of drug-susceptible and drug-resistant cases, preventive therapy in the newborn, adherence and completion, and programme monitoring
- Definitions and patient registration: case definitions, classification of tuberculosis and treatment outcome definitions
- Treatment of drug-susceptible tuberculosis: objectives, anti-tuberculosis drug dosing and the standard regimens
- Drug-resistant tuberculosis and leprosy, each with its own diagnosis and treatment pathway
Who it is for
TB focal persons and clinicians in health centres and hospitals, laboratory staff running diagnostic algorithms, pharmacy staff handling anti-TB medicines, and the woreda, zonal and regional programme officers responsible for registration, reporting and outcome monitoring. Leprosy services in Ethiopia are managed through the same programme structure, which is why both sit in one document.
The sections that get used most
In practice three parts of this guideline are opened far more often than the rest. The case definitions and classifications decide how a patient is registered, and registration drives everything downstream. The treatment outcome definitions determine whether a case is recorded as cured, completed, failed, lost to follow-up or not evaluated, which is what programme performance is judged on. And the latent TB infection chapter is the part most likely to differ from what a clinician learned earlier, since national policy on preventive therapy has moved considerably.
Common questions
Which edition is this? The Sixth Edition, dated November 2017.
Does it cover both TB and leprosy? Yes. Both are managed under the same national programme in Ethiopia and both are in this document, along with drug-resistant TB.
Where are the drug doses? In the treatment chapters, which give anti-tuberculosis drug dosing and the standard regimens for drug-susceptible disease, with separate regimens for drug-resistant disease.
Is it free to download? Yes. It is a Ministry of Health publication and this copy is the publisher’s own file, with no login and no charge.
About this copy
Hosted unchanged as the publisher issued it. Publisher, year and file size are in the panel above. Facilities should confirm with their regional health bureau which edition is currently in force locally.
How TB services are organised in Ethiopia
The guideline assumes the standard programme structure: diagnosis and treatment initiation at health centre and hospital level, a treatment supporter for the continuation phase, and registration into the national recording system at the treating facility. Drug-resistant cases follow a separate pathway with a defined set of treatment initiating centres and closer laboratory monitoring. Understanding which pathway a patient is on matters, because the registration category, the follow-up schedule and the outcome definitions all differ between them.
The same structure is why the guideline devotes so much space to recording and reporting. A TB programme is judged on cohort outcomes, and cohort outcomes are only as good as the registration decisions made at the point of diagnosis. Clinicians who treat correctly but register inconsistently produce a programme that cannot tell whether it is working.
Get new Ethiopian clinical guidelines by email
One short message when a new national guideline, protocol or standard is added to this library. The download above stays free either way.
No spam, unsubscribe any time. Privacy policy.
Related documents
Other guidelines and protocols on the same subject.
- TB, DR TB and Leprosy GuidelinePDF
- Ethiopia National Guideline for Leprosy Control 2021
- Ethiopia National Strategy for Prevention and Control of Viral Hepatitis (2016)PDF
- National Guideline for Scabies ManagementPDF
- Ethiopia National Malaria Guidelines – Fourth Edition, November 2017PDF
- Ethiopia National Guideline for Prevention of Mother-to-Child Transmission of HIV, Syphilis and Hepatitis B Virus (2021)PDF
